Other languages Mankind Pharma Limited

Equities

MANKIND

INE634S01028

Delayed NSE India S.E. Other stock markets 04:05:27 2024-06-10 am EDT			5-day change	1st Jan Change
2,170 ^INR	+2.00%		+2.09%	+9.46%

May. 30	Advent International Receives 6-7 Bids for Bharat Serums	CI
May. 16	Transcript : Mankind Pharma Limited, Q4 2024 Earnings Call, May 16, 2024

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Advent International Receives 6-7 Bids for Bharat Serums	May. 30
Mankind Pharma's Consolidated Profit Jumps in Fiscal Q4	May. 16
India's Mankind Pharma's Q4 profit jumps on strength in chronic drugs segment	May. 15
Mankind Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	May. 15
India's weight in key MSCI equity index hits another high, to boost inflows	May. 14
Mankind Pharma Reportedly in Fray to Acquire Advent's Stake in Bharat Serums	May. 14
KKR, Novo Nordisk, Others Reportedly Bid for Healthium Buy	May. 02
CARE Gives AA+ Rating to Mankind Pharma's Long-term Bank Financing; Outlook Stable	Apr. 26
Mankind Pharma to Sell its Over the Counter Business on Slump Sale Basis	Apr. 03
Mankind Pharma to Sell OTC Business to Wholly-Owned Subsidiary	Apr. 03
Mankind Pharma to Form New Subsidiary for Consumer Healthcare Products	Apr. 02
Mankind Pharma Limited Announces Incorporation of Wholly Owned Subsidiary Mankind Consumer Products Private Limited	Apr. 02
Mankind Reportedly Joins Race for Healthium Medtech	Mar. 28
AstraZeneca, Mankind Pharma Tie Up for Exclusive Distribution of Asthma Drug Symbicort in India	Mar. 11
Astrazeneca Pharma India Ltd and Mankind Pharma Partner to Accelerate Access to Asthma Medicine for Patients in India	Mar. 11
India's Jubilant Pharmova posts quarterly profit	Feb. 02
Mankind Pharma Posts Gains in Fiscal Q3 Consolidated Net Profit; Shares Rise 3%	Feb. 01
India's Mankind Pharma beats Q3 profit estimates on strong demand	Jan. 31
Mankind Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 31
India's IPO momentum seen growing on prospects of political stability	Dec. 19

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Mankind Pharma Limited

Equities

MANKIND

INE634S01028

Other languages

Filters